Trump signed an executive order directing agencies to speed psychedelic research and approvals, alongside $50 million in federal funding for treatments such as ibogaine. ・FDA Commissioner Marty Makary ...

The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.

The drugs, which include mind-altering substances like LSD and ecstasy, are sometimes used to treat disorders like depression ...

UCSF Ralph Metzner Distinguished Professor in Neurology and Psychiatry Robin Carhart-Harris, PhD, is among the world’s first ...

Military veterans may eventually see newer forms of mental health relief by way of treatments being greenlighted by the ...